Effect of lipoarabinomannan (M. smegmatis) on RAW 264.7 murine macrophage nitric oxide production

Location

Virtual | Room 4

Access Type

Campus Access Only

Entry Number

64

Start Date

4-7-2021 11:15 AM

End Date

4-7-2021 11:30 AM

Department

Biomedical Science

Abstract

Tuberculosis (TB) is a respiratory disease caused by the pathogenic bacteria Mycobacterium tuberculosis and is the leading cause of death by an infectious agent worldwide. Alveolar mammalian macrophages have a vigorous innate immune response to bacterial cell walls composed of Lipopolysaccharide (LPS). Unlike most bacteria, the Mycobacterium genus has a unique cell wall composition including Lipoarabinomannan (LAM). LAM is known to act through Toll-like receptor 2 (TLR-2), while LPS acts on TLR-4. In order to develop effective treatments for TB, we must better understand the disease process and how M. tuberculosis interacts with macrophages. RAW 264.7 mouse macrophages were maintained in culture by passage every 4 days and used for experiments at the time of passage. When stimulated with LPS, macrophages produce nitric oxide (NO) through the enzyme inducible nitric oxide synthase (iNOS). RAW 264.7 murine macrophages were stimulated in a dose-response fashion with LPS (0-100ng/mL) and M. smegatis-derived LAM (100-5000ng/mL). Nitrite levels in cell supernatant from treatment were measured using a Griess reaction and quantitated using a spectrophotometer. The current results indicate that LAM triggers a response (50ng/mL nitrite per 5000µL) but not as extreme as LPS treatment (90ng/mL nitrite per 100µL). LAM may act on TLR-4, producing NO through iNOS. The LAM reagent may be contaminated by endotoxin, which would stimulate TLR-4, or LAM may stimulate both TLR-2 and TLR-4 (to a lesser extent). Planned experiments using TLR-4 antagonist LPS-RS (Rhodobacter sphaeroides) should isolate the LAM response.

Faculty Mentor(s)

Dr. David O. Freier

Rights Statement

The right to download or print any portion of this material is granted by the copyright owner only for personal or educational use. The author/creator retains all proprietary rights, including copyright ownership. Any editing, other reproduction or other use of this material by any means requires the express written permission of the copyright owner. Except as provided above, or for any other use that is allowed by fair use (Title 17, §107 U.S.C.), you may not reproduce, republish, post, transmit or distribute any material from this web site in any physical or digital form without the permission of the copyright owner of the material.

This document is currently not available here.

Share

COinS
 
Apr 7th, 11:15 AM Apr 7th, 11:30 AM

Effect of lipoarabinomannan (M. smegmatis) on RAW 264.7 murine macrophage nitric oxide production

Virtual | Room 4

Tuberculosis (TB) is a respiratory disease caused by the pathogenic bacteria Mycobacterium tuberculosis and is the leading cause of death by an infectious agent worldwide. Alveolar mammalian macrophages have a vigorous innate immune response to bacterial cell walls composed of Lipopolysaccharide (LPS). Unlike most bacteria, the Mycobacterium genus has a unique cell wall composition including Lipoarabinomannan (LAM). LAM is known to act through Toll-like receptor 2 (TLR-2), while LPS acts on TLR-4. In order to develop effective treatments for TB, we must better understand the disease process and how M. tuberculosis interacts with macrophages. RAW 264.7 mouse macrophages were maintained in culture by passage every 4 days and used for experiments at the time of passage. When stimulated with LPS, macrophages produce nitric oxide (NO) through the enzyme inducible nitric oxide synthase (iNOS). RAW 264.7 murine macrophages were stimulated in a dose-response fashion with LPS (0-100ng/mL) and M. smegatis-derived LAM (100-5000ng/mL). Nitrite levels in cell supernatant from treatment were measured using a Griess reaction and quantitated using a spectrophotometer. The current results indicate that LAM triggers a response (50ng/mL nitrite per 5000µL) but not as extreme as LPS treatment (90ng/mL nitrite per 100µL). LAM may act on TLR-4, producing NO through iNOS. The LAM reagent may be contaminated by endotoxin, which would stimulate TLR-4, or LAM may stimulate both TLR-2 and TLR-4 (to a lesser extent). Planned experiments using TLR-4 antagonist LPS-RS (Rhodobacter sphaeroides) should isolate the LAM response.